Salvage chemotherapy With CPT-11 for recurrent meningioma

被引：0
|
作者：
Marc C. Chamberlain
Denice D. Tsao-Wei
Susan Groshen
机构：
[1] Moffitt Cancer Center and Research Institute,Department of Interdisciplinary Oncology
[2] USC/Norris Cancer Center,Department of Preventive Medicine
来源：
Journal of Neuro-Oncology | 2006年 / 78卷
关键词：
CPT-11; meningioma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：271 / 276
页数：5
相关论文
共 50 条
  • [31] Pharmacokinetics of CPT-11 in rhesus monkeys
    Inaba M.
    Ohnishi Y.
    Ishii H.
    Tanioka Y.
    Yoshida Y.
    Sudoh K.
    Hakusui H.
    Mizuno N.
    Ito K.
    Sugiyama Y.
    Cancer Chemotherapy and Pharmacology, 1997, 41 (2) : 103 - 108
  • [32] Irinotecan (CPT-11) for multiple myeloma
    Yano, H.
    Iida, S.
    Kayukawa, S.
    Nakagawa, C.
    Oguri, T.
    Ri, M.
    Inagaki, A.
    Sanda, T.
    Kusumoto, S.
    Ishida, T.
    Komatsu, H.
    Suzuki, A.
    Ueda, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 140 - 140
  • [33] CPT-11临床应用进展
    彭云武
    现代肿瘤医学, 2009, 17 (08) : 1594 - 1598
  • [34] Clinical pharmacogenetics of irinotecan (CPT-11)
    Ando, Y
    Hasegawa, Y
    DRUG METABOLISM REVIEWS, 2005, 37 (03) : 565 - 574
  • [35] Efficacy analyses of a randomized phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advanced or recurrent gastric cancer refractory to prior S-1 chemotherapy
    Inagaki, Hitoshi
    Nishikawa, Kazuhiro
    Fujitani, Kazumasa
    Sugimoto, Naotoshi
    Shigematsu, Tadashi
    Ishiguro, Tohru
    Tsuburaya, Akira
    Nakamura, Masato
    Nashimoto, Atsushi
    Yamane, Takao
    Yamada, Makoto
    Imano, Motohiro
    Iijima, Shohei
    Oka, Yoshio
    Kataoka, Masato
    Hironaka, Shuichi
    Andoh, Hideaki
    Morita, Satoshi
    Sakamoto, Junichi
    Tsujinaka, Toshimasa
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [36] Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer
    Elliot Newman
    Stuart G. Marcus
    Milan Potmesil
    Sanjeev Sewak
    Herman Yee
    Joan Sorich
    Mary Hayek
    Franco Muggia
    Howard Hochster
    Journal of Gastrointestinal Surgery, 2002, 6 : 212 - 223
  • [37] Irinotecan (CPT-11): A brief overview
    Rivory, LP
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 (10-11) : 1000 - 1004
  • [38] Clinical pharmacogenetics of irinotecan (CPT-11)
    Ando, Y
    DRUG METABOLISM REVIEWS, 2004, 36 : 16 - 16
  • [39] Pharmacokinetics of CPT-11 in rhesus monkeys
    Inaba, M
    Ohnishi, Y
    Ishii, H
    Tanioka, Y
    Yoshida, Y
    Sudoh, K
    Hakusui, H
    Mizuno, N
    Ito, K
    Sugiyama, Y
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 41 (02) : 103 - 108
  • [40] Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinoma (NPC).
    Poon, D
    Chowbay, B
    Leong, SS
    Cheung, YB
    Toh, CK
    Tay, MH
    Lim, WT
    Tan, EH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 507S - 507S
12345